NCT01075204 - Clarithromycin Modified Release Observational Study for Evaluation of Treatment, Tolerability & Recovery Time in Saudi & Egyptian Clinical Settings (CLOSER) | Biotech Hunter

Enrollment

335

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Respiratory Tract Infection

Interventions

DRUG

clarithromycin modified release 500 mg

clarithromycin modified release 500 mg for 7 days

Trial Locations (12)

Site Ref # / Investigator 22543, Jeddah

Site Ref # / Investigator 50162, Cairo

Site Ref # / Investigator 50215, Cairo

Site Ref # / Investigator 50225, Cairo

Site Ref # / Investigator 50235, Cairo

Site Ref # / Investigator 50236, Cairo

Site Ref # / Investigator 50237, Cairo

Site Ref # / Investigator 51204, Cairo

Site Ref # / Investigator 51205, Cairo

Site Ref # / Investigator 50213, Helwan

Site Ref # / Investigator 51206, Tanta

Site Ref # / Investigator 51207, Tanta